R&D TEAM The company has established a research and development team led by national "Thousand Talents Plan", Sichuan Province "Thousand Talents Plan", and Chengdu specially hired experts, focusing on the research and industrialization of high-end protective amino acids. It has multiple doctoral candidates as technical backbone, and more than 50 employees with master's, bachelor's, and high/intermediate technical titles. TESTING CENTER The research and development laboratory has not only multiple reactors of various models and conventional research and development equipment such as high-performance liquid chromatography (HPLC), but also multiple advanced instruments and equipment, including liquid mass spectrometry (LCMS), infrared spectroscopy, HPLC, ion chromatography, gas chromatography, headspace sampler, polarimeter, automatic moisture analyzer, melting point analyzer, etc. In 2023, the company invested in purchasing 1,000 mu of land in the Lanzhou New Area Chemical Park, Gansu Province, and began the construction of a new first-phase factory covering an area of about 280 mu. The construction has now been completed, with an annual production capacity exceeding 2,000 tons. The second phase of the new factory project is currently in the planning stage. PRODUCTION BASE & CAPACITY QUALITY ASSURANCE Passed the certification of ISO9001:2015 quality management system in June 2019;
The company establishes a quality management system, including the formulation of quality standards for raw materials, intermediates, and products;
Detection ability: In addition to routine detection items, products can also be identified through IR, NMR, MS, and can also be tested for isomers, residual solvents, and other items. PRODUCT MARKETING To provide various standardized protective amino acid products and process technology services to global customers, adhering to the leading domestic brand image of protective amino acids;
We are guided by customer needs, continuously innovating, and responding quickly. Continuously develop new products and technologies according to customer needs;
The company's products have occupied more than 60% of the domestic market share in this industry, and in 2016, they passed audits by more than 40 large domestic and foreign pharmaceutical companies. |